Evidence map›Paper›PMID 40691431›Full record

ArticleAnnals of surgical oncology2025

The Effect of Oncoplastic Reduction Mammoplasty on the Incidence of Breast Lymphedema in Women Undergoing Breast Conservation Surgery.

Andrew Hannoudi, Madeleine R Gonte, Cara Cannella, Kinan Sawar, Summer S Yono, Noah M Atisha, Eleanor M Walker, Jessica Bensenhaver, Maristella S Evangelista, Dunya M Atisha

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andrew HannoudiWayne State University School of Medicine, 540 E Canfield St., Detroit, MI, 48201, USA. gu8960@wayne.edu.ORCID http://orcid.org/0000-0003-4300-3618
Madeleine R GonteWayne State University School of Medicine, 540 E Canfield St., Detroit, MI, 48201, USA.
Cara CannellaDivision of Plastic and Reconstructive Surgery, Henry Ford Hospital, Detroit, MI, USA.
Kinan SawarWayne State University School of Medicine, 540 E Canfield St., Detroit, MI, 48201, USA.
Summer S YonoDivision of Plastic and Reconstructive Surgery, Henry Ford Hospital, Detroit, MI, USA.
Noah M AtishaDivision of Plastic and Reconstructive Surgery, Henry Ford Hospital, Detroit, MI, USA.
Eleanor M WalkerDivision of Plastic and Reconstructive Surgery, Henry Ford Hospital, Detroit, MI, USA.
Jessica BensenhaverDivision of Plastic and Reconstructive Surgery, Henry Ford Hospital, Detroit, MI, USA.
Maristella S EvangelistaDivision of Plastic and Reconstructive Surgery, Henry Ford Hospital, Detroit, MI, USA.
Dunya M AtishaDivision of Plastic and Reconstructive Surgery, Henry Ford Hospital, Detroit, MI, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWomen with macromastia are susceptible to less favorable postoperative outcomes following breast conservation surgery (BCS). Among those, breast lymphedema is a severe complication that impacts functional and aesthetic outcomes. However, effective prevention strategies remain understudied. We aim to assess whether women with macromastia who receive oncoplastic reduction mammoplasty (ORM) have reduced incidence of postoperative breast lymphedema compared with patients who receive BCS alone.

methodsA retrospective analysis of patients who underwent BCS alone or ORM followed by radiation was conducted. Demographics, treatment details, operative techniques, and postoperative outcomes were compared between BCS alone and ORM groups using inferential statistics. A subanalysis was similarly conducted to identify differences in postoperative outcomes between women with and without macromastia. Regression analysis was used to evaluate the effects of ORM and the factors associated with breast lymphedema.

resultsThe overall incidence of breast lymphedema was 10.6%. Black race, preoperative breast volume ≥ 1500 cm

conclusionsWomen with macromastia who receive BCS alone have an increased incidence of postoperative breast lymphedema. Oncoplastic reduction mammoplasty is an alternative treatment option that reduces the likelihood of postoperative breast lymphedema compared with BCS alone in patients with breast volumes ≥ 1500 cm

Identifiers

PMID40691431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.